Cargando…

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation

Vascularized composite allotransplantations (VCAs) are not routinely performed for tissue reconstruction because of the potentially harmful adverse effects associated with lifelong administration of immunosuppressive agents. Researchers have been eagerly seeking alternative methods that circumvent t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Yur-Ren, Chen, Chien-Chang, Goto, Shigeru, Lin, Pao-Yuan, Wei, Fu-Chan, Chen, Chao-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514826/ https://www.ncbi.nlm.nih.gov/pubmed/23227090 http://dx.doi.org/10.1155/2012/854846

Ejemplares similares

Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in a Swine Hemi-Facial Allotransplantation Model
por: Kuo, Yur-Ren, et al.
Publicado: (2012)

Perspectives on the Use of Mesenchymal Stem Cells in Vascularized Composite Allotransplantation
por: Plock, Jan A., et al.
Publicado: (2013)

Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite Allotransplantation
por: Heyes, Richard, et al.
Publicado: (2016)

KRP-203 Is a Desirable Immunomodulator for Islet Allotransplantation
por: Fathi, Ibrahim, et al.
Publicado: (2021)

Abstract: Immunomodulation in Vascularized Composite Allotransplantation – Preliminary Results in a Non-human Primate Model with Tocilizumab
por: Ng, Zhi Yang, et al.
Publicado: (2016)

Split Rejection in Vascularized Composite Allotransplantation
por: Sinha, Indranil, et al.
Publicado: (2013)

Costimulation Blockade in Vascularized Composite Allotransplantation
por: Giannis, Dimitrios, et al.
Publicado: (2020)

Vascularized Composite Allotransplantation: Medical Complications
por: Uluer, Mehmet C., et al.
Publicado: (2016)

Sensitization and Desensitization in Vascularized Composite Allotransplantation
por: Moris, Dimitrios, et al.
Publicado: (2021)

Cell therapy in vascularized composite allotransplantation
por: Anggelia, Madonna Rica, et al.
Publicado: (2022)

Perfusion decellularization for vascularized composite allotransplantation
por: Nicholls, Danielle L, et al.
Publicado: (2022)

Patient Advocacy in Vascularized Composite Allotransplantation
por: Benedict, James
Publicado: (2022)

Preclinical Studies in Vascularized Composite Allotransplantation
por: Grosu-Bularda, Andreea, et al.
Publicado: (2023)

Adipose-derived stromal cells modulating composite allotransplant survival is correlated with B cell regulation in a rodent hind-limb allotransplantation model
por: Chen, Chien-Chang, et al.
Publicado: (2020)

The Need for Inducing Tolerance in Vascularized Composite Allotransplantation
por: Ravindra, Kadiyala V., et al.
Publicado: (2012)

Current status of vascularized composite tissue allotransplantation
por: Edtinger, Karoline, et al.
Publicado: (2014)

Kidney Dysfunction After Vascularized Composite Allotransplantation
por: Krezdorn, Nicco, et al.
Publicado: (2018)

Recellularization of Bioengineered Scaffolds for Vascular Composite Allotransplantation
por: Adil, Aisha, et al.
Publicado: (2022)

Composite Tissue Allotransplantation Immunology
por: Eun, Seok Chan
Publicado: (2013)

TRFs and tiRNAs sequence in acute rejection for vascularized composite allotransplantation
por: Fang, Yuan, et al.
Publicado: (2022)

Bioimaging of alloantigen-stimulated regulatory T cells in rat vascularized composite allotransplantation
por: Cheng, Hui-Yun, et al.
Publicado: (2018)

Potential Roles of miRNAs in Acute Rejection for Vascularized Composite Allotransplantation
por: Li, Haibo, et al.
Publicado: (2022)

Tumescent Technique in Vascularized Composite Allotransplantation Secondary Surgery
por: Thione, Alessandro, et al.
Publicado: (2016)

Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
por: Starzl, Ravi, et al.
Publicado: (2013)

Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential
por: Schnider, Jonas T., et al.
Publicado: (2013)

A Call to Accountability: Reporting Outcomes in Vascularized Composite Allotransplantation
por: Benedict, James L., et al.
Publicado: (2019)

Implications of Vascularized Composite Allotransplantation in Plastic Surgery on Legal Medicine
por: Haug, Valentin, et al.
Publicado: (2023)

Ensuring Racial and Ethnic Inclusivity in Facial Vascularized Composite Allotransplantation
por: Kauke-Navarro, Martin, et al.
Publicado: (2023)

Cellular activation pathways and interaction networks in vascularized composite allotransplantation
por: Knoedler, Leonard, et al.
Publicado: (2023)

Psychosocial and bioethical challenges and developments for the future of vascularized composite allotransplantation: A scoping review and viewpoint of recent developments and clinical experiences in the field of vascularized composite allotransplantation
por: Kumnig, Martin, et al.
Publicado: (2022)

Composite Tissue Allotransplantation and Dysregulation in Tissue Repair and Regeneration: A Role for Mesenchymal Stem Cells
por: Antony, Anuja K., et al.
Publicado: (2013)

Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation
por: Londono, Ricardo, et al.
Publicado: (2016)

A chronic rejection model and potential biomarkers for vascularized composite allotransplantation
por: Puscz, Flemming, et al.
Publicado: (2020)

Preservation solutions for attenuation of ischemia–reperfusion injury in vascularized composite allotransplantation
por: Datta, Shaishav, et al.
Publicado: (2021)

Editorial: Psychosocial and bioethical challenges and developments for the future of vascularized composite allotransplantations
por: Kumnig, Martin, et al.
Publicado: (2023)

Defining chronic rejection in vascularized composite allotransplantation—The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation
por: Kaufman, Christina L, et al.
Publicado: (2020)

Tolerance Induction Strategies in Vascularized Composite Allotransplantation: Mixed Chimerism and Novel Developments
por: Leonard, David A., et al.
Publicado: (2012)

Evolving ethics, policy and reimbursement issues of vascularized composite allotransplantation: Symposium summary
por: Rose, John, et al.
Publicado: (2019)

Using team science in vascularized composite allotransplantation to improve team and patient outcomes
por: Griffin, Joan M., et al.
Publicado: (2022)

Tolerance Induction in Vascularized Composite Allotransplantation—A Brief Review of Preclinical Models
por: Huelsboemer, Lioba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_omsv6ctvecdcm4s45vusodvp91